Botanix Pharmaceuticals Ltd Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Vincent Ippolito, was filed 24 Apr 2026.
Botanix Pharmaceuticals Ltd: what insiders have been doing
Botanix Pharmaceuticals Ltd belongs to the Health Care sector. Filings by its managers are published through ASX. In the past year (19 October 2025 to 19 October 2026), 5 filings came from 4 insiders.
On the market, 1 insider bought (1 purchase) while 1 insider sold (1 sale). The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 senior executive.
The clock since the last published purchase (24 April 2026) now reads 198 days. The median gap between a trade and its publication by ASX is 4 days. Until a filing is published, the market cannot know about the trade.
Across the 1,605 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. Over the whole record (from 2026), the tally stands at 1 purchase and 1 sale.
Elsewhere in the same sector, our signals recently picked up insider purchases at Vivos Inc and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -59.4%Entry A$0.03 · Close 16 Oct 2026 A$0.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXASX:2924-03149767-6A1349838
- ShareASXASX:2924-03149761-6A1349834
- 00.0000% mcap50.5% of flowShareASXISIN AU000000BOT2ASX:2924-03138734-6A1345176
- 1,000,000 sharesShareASXISIN AU000000BOT2ASX:2924-03129391-6A1341324
- 1,666,667 shares49.5% of flowShareASXISIN AU000000BOT2ASX:2924-03082305-6A1321946Canonical exit: 19 Jul 2026 (T+90)
5 of 5 declarations
About Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Ltd is a company focused on developing cannabinoid-based treatments for dermatological conditions and other diseases. It is listed on the XASX market.
